Corvidia

Biopharma takeovers show quantity, if not quality
EP Vantage
Mon, 07/13/20 - 11:13 am
COVID-19
pandemic
M&A
Novo Nordisk
Corvidia
Gilead Sciences
Pionyr
Alexion
Portola Pharmaceuticals
Menarini
Stemline Therapeutics
Shionogi
Tetra Therapeutics
Novo Nordisk Strikes a $725M Deal for AstraZeneca Spinout Corvidia
Xconomy
Thu, 06/11/20 - 10:38 pm
Novo Nordisk
M&A
Corvidia
kidney disease
Biotech vet grabs AstraZeneca drug, $26M to start building a new cardio biotech
Fierce Biotech
Thu, 02/18/16 - 05:39 pm
AstraZeneca
Epanova
COR-001
Corvidia